FDA Clearance Tracker · P170038-S001
CentriMag Circulatory Support System
Last checked: Nov 20, 2026Latest source record: Mar 20, 2020 (this decision)Source: openFDAMethods & limitations
Decided
Mar 20, 2020
Approved
Time to decision
72 days
Received Jan 8, 2020. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P170038-S001
- Device name
- CentriMag Circulatory Support System
- Applicant
- Abbott
- Applicant location
- Pleasanton, CA
- Received
- Jan 8, 2020
- Decided
- Mar 20, 2020
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Location Change - Manufacturer/Sterilizer/Packager/Supplier
- Original approval
- P170038
Device type
- Device type
- Ventricular (assist) bypass (DSQ)
- Device class
- Class III
- Specialty
- Cardiology
FDA's approval statement
As written in FDA's record.
Aproval for a manufacturing site located at Gerresheimer Regensburg GmbH in Pfreimd, Germany for assembling and packaging the blood pump.
Source documents
Other decisions for Abbott
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
P260019 · Decided Oct 27, 2026 · 180 days after receipt
Device type: Para-device leak occluder (SJT) · Cardiology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.